Deerfield Management Company, L.P. (Series C) Portfolio Holdings

Deerfield Management Company, L.P. (Series C)

  • $4.35 Billion
  • Q2 2025

Deerfield Management Company, L.P. (Series C) has filed its 13F form on August 14, 2025 for Q2 2025 where it was disclosed a total value porftolio of $4.35 Billion distributed in 124 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Nuvalent, Inc. with a value of $1.37B, Oscar Health, Inc. with a value of $250M, Viatris Inc with a value of $215M, Merus N.V. with a value of $178M, and Centene Corp with a value of $173M.

Examining the 13F form we can see an increase of $397M in the current position value, from $3.95B to 4.35B.

Deerfield Management Company, L.P. (Series C) is based out at New York, NY

Below you can find more details about Deerfield Management Company, L.P. (Series C) portfolio as well as his latest detailed transactions.

Portfolio value $4.35 Billion
Healthcare: $4.33 Billion
Real Estate: $22.4 Million
Industrials: $321,000
Financial Services: $204,000

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$1.96B
$7.31 Million 0.17% of portfolio
225,000
Q3 2024 New
$230M
$6.89 Million 0.16% of portfolio
3,360,052
Q3 2022 Reduced 0.68%
$291M
$6.18 Million 0.14% of portfolio
354,089
Q1 2025 New
$243M
$5.57 Million 0.13% of portfolio
500,000
Q1 2025 New
$3.06B
$4.8 Million 0.11% of portfolio
342,558
Q2 2025 Reduced 92.5%
$63M
$4.9 Million 0.11% of portfolio
1,890,000
Q1 2025 Added 23.15%
$69.9M
$3.75 Million 0.09% of portfolio
1,882,654
Q3 2024 Reduced 52.98%
$237M
$1.48 Million 0.03% of portfolio
1,055,192
Q1 2025 Reduced 1.1%
$111M
$1.4 Million 0.03% of portfolio
583,913
Q1 2021 Reduced 50.0%
$1.44B
$876,000 0.02% of portfolio
23,827
Q4 2024 Added 1.72%
$35.3B
$224,000 0.01% of portfolio
917
Q4 2024 New
$1.79B
$313,000 0.01% of portfolio
2,926
Q2 2025 New
$4.56B
$503,000 0.01% of portfolio
45,242
Q2 2025 New
$1.74B
$364,000 0.01% of portfolio
11,138
Q2 2025 New
$10.6B
$368,000 0.01% of portfolio
1,945
Q2 2025 New
$3.28B
$269,000 0.01% of portfolio
2,744
Q2 2025 New
$1.41B
$219,000 0.01% of portfolio
9,579
Q2 2025 New
$1.14B
$294,000 0.01% of portfolio
13,670
Q2 2025 New
$15.5B
$231,000 0.01% of portfolio
736
Q2 2025 New
$783M
$240,000 0.01% of portfolio
39,351
Q2 2025 New
$1.52B
$370,000 0.01% of portfolio
1,517
Q2 2025 New
$12.2B
$299,000 0.01% of portfolio
2,101
Q2 2025 New
$2.07B
$346,000 0.01% of portfolio
4,169
Q2 2025 New
$1.71B
$321,000 0.01% of portfolio
10,267
Q2 2025 New
$193B
$371,000 0.01% of portfolio
916
Q2 2025 New
$12.5B
$289,000 0.01% of portfolio
1,597
Q2 2025 New
$2.74B
$263,000 0.01% of portfolio
3,529
Q2 2025 New
$35.4B
$255,000 0.01% of portfolio
1,623
Q2 2025 New
$4.23B
$85,000 0.0% of portfolio
1,506
Q2 2025 New
$70.5B
$204,000 0.0% of portfolio
1,310
Q2 2025 New
$6.63B
$202,000 0.0% of portfolio
1,628
Q2 2025 New
Zenas Biopharma Inc
-
$0 0.0% of portfolio
-
Q3 2024 New
$0
$62,000 0.0% of portfolio
1,250,000
Q4 2021 New
$6.22B
$213,000 0.0% of portfolio
1,805
Q2 2025 New
Sionna Therapeutics Inc
-
$0 0.0% of portfolio
-
Q2 2025 Added 29.93%
Tandem Diabetes Care Inc
-
$0 0.0% of portfolio
-
Q2 2025 New
$0
$3,000 0.0% of portfolio
166,666
Q3 2021 New
Xeris Biopharma Holdings Inc
-
$0 0.0% of portfolio
-
Q1 2025 New
$1.05B
$105,000 0.0% of portfolio
22,574
Q2 2025 New
Spyre Therapeutics Inc
-
$0 0.0% of portfolio
-
Q2 2025 Added 36.37%
Structure Therapeutics Inc
-
$0 0.0% of portfolio
-
Q4 2024 Reduced 55.78%
-
$0 0.0% of portfolio
-
Q2 2021 New
Praxis Precision Medicines I
-
$0 0.0% of portfolio
-
Q2 2025 Added 10.81%
$410M
$11,000 0.0% of portfolio
1,872
Q2 2025 New
Disc Medicine Inc
-
$0 0.0% of portfolio
-
Q2 2025 Added 17.52%
$142B
$33,000 0.0% of portfolio
168
Q2 2025 New
$1.54B
$204,000 0.0% of portfolio
1,993
Q2 2025 New
Cooper Cos Inc
-
$0 0.0% of portfolio
-
Q2 2025 New
$404M
$189,000 0.0% of portfolio
55,703
Q2 2025 Added 375.4%

Summary

  • Portfolio
  • No. of Stocks 124
  • Current Value $4.35 Billion
  • Prior Value $3.95 Billion
  • Filing
  • Period Q2 2025
  • Filing Date August 14, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 45 stocks
  • Additional Purchases 28 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 13 stocks
Track This Portfolio

Track Deerfield Management Company, L.P. (Series C) Portfolio

Follow Deerfield Management Company, L.P. (Series C) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deerfield Management Company, L.P. (Series C), based on Form 13F filings with the SEC.

News

Stay updated on Deerfield Management Company, L.P. (Series C) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email